Holen Sie sich die Stockscreener-App
0.718
0.80%
-0.0058
Handel nachbörslich:
.71
-0.008
-1.11%
Schlusskurs vom Vortag:
$0.7238
Offen:
$0.7238
24-Stunden-Volumen:
184.43K
Relative Volume:
0.33
Marktkapitalisierung:
$37.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.22M
KGV:
-0.2426
EPS:
-2.96
Netto-Cashflow:
$-74.41M
1W Leistung:
+3.98%
1M Leistung:
+9.27%
6M Leistung:
-16.34%
1J Leistung:
-12.06%
1-Tages-Spanne:
$0.7002
$0.7268
1-Wochen-Bereich:
$0.6706
$0.7609
52-Wochen-Spanne:
$0.615
$1.70
Xilio Therapeutics Inc Stock (XLO) Company Profile
Firmenname
Xilio Therapeutics Inc
Sektor
Branche
Telefon
617-833-1027
Adresse
828 WINTER STREET, WALTHAM
Vergleichen Sie XLO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XLO
Xilio Therapeutics Inc
|
0.718 | 36.52M | 0 | -81.22M | -74.41M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Eingeleitet | Leerink Partners | Outperform |
| 2022-12-21 | Eingeleitet | Chardan Capital Markets | Buy |
| 2022-01-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-16 | Eingeleitet | Cowen | Outperform |
| 2021-11-16 | Eingeleitet | Guggenheim | Buy |
| 2021-11-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-11-16 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Xilio Therapeutics Inc Aktie (XLO) Neueste Nachrichten
Xilio Therapeutics Inc. stock daily chart insightsPortfolio Return Report & Low Risk High Reward Trade Ideas - Newser
Institutional scanner results for Xilio Therapeutics Inc.Bear Alert & Expert Curated Trade Setups - Newser
Is Xilio Therapeutics Inc.’s ROE strong enough2025 Momentum Check & Fast Momentum Entry Tips - khodrobank.com
What’s the recovery path for long term holders of Xilio Therapeutics Inc.Earnings Beat & High Accuracy Swing Entry Alerts - Newser
Xilio Therapeutics Faces Nasdaq Equity Compliance Challenge - MSN
Xilio Therapeutics Inc. stock retracement – recovery analysisGDP Growth & Verified High Yield Trade Plans - Newser
Risk adjusted return profile for Xilio Therapeutics Inc. analyzedTrade Ideas & AI Enhanced Trading Signals - Newser
Will earnings trigger a reversal in Xilio Therapeutics Inc.Market Growth Summary & Weekly Setup with High ROI Potential - Newser
Should you hold or exit Xilio Therapeutics Inc. now2025 Market Outlook & Reliable Breakout Forecasts - Newser
Can you recover from losses in Xilio Therapeutics Inc.2025 Major Catalysts & Weekly Sector Rotation Insights - Newser
What MACD and RSI say about Xilio Therapeutics Inc.Global Markets & Daily Price Action Insights - Newser
Developing predictive dashboards with Xilio Therapeutics Inc. data2025 Earnings Surprises & Entry Point Strategy Guides - Newser
Using RSI to spot recovery in Xilio Therapeutics Inc.Weekly Profit Summary & Safe Capital Investment Plans - Newser
How institutional ownership impacts Xilio Therapeutics Inc. stockEntry Point & Expert Curated Trade Setup Alerts - Newser
Identifying reversal signals in Xilio Therapeutics Inc.July 2025 PostEarnings & Community Verified Trade Signals - Newser
Is Xilio Therapeutics Inc. forming a double bottom2025 Momentum Check & AI Forecasted Stock Moves - خودرو بانک
Analyzing net buyer seller activity in Xilio Therapeutics Inc.Portfolio Performance Report & Accurate Buy Signal Alerts - Newser
What makes Xilio Therapeutics Inc. stock price move sharply2025 Buyback Activity & Reliable Momentum Entry Alerts - Newser
Xilio Therapeutics Inc. Flashes Buy Signal on Multi Timeframe Chart getLinesFromResByArray error: size == 0 - 클래시안
Visual trend scoring systems applied to Xilio Therapeutics Inc.July 2025 WrapUp & Low Volatility Stock Suggestions - Newser
Will earnings trigger a reversal in Xilio Therapeutics IncTrade Exit Summary & Real-Time Market Sentiment Reports - Newser
Analyzing drawdowns of Xilio Therapeutics Inc. with statistical toolsIndex Update & Proven Capital Preservation Methods - Newser
Advanced analytics toolkit walkthrough for Xilio Therapeutics Inc.Options Play & Free Community Supported Trade Ideas - Newser
Should you wait for a breakout in Xilio Therapeutics Inc.Weekly Profit Analysis & Trade Opportunity Analysis Reports - Newser
What indicators show strength in Xilio Therapeutics Inc.Trade Signal Summary & Safe Entry Zone Identification - Newser
What to do if you’re stuck in Xilio Therapeutics Inc.Breakout Watch & Real-Time Buy Signal Alerts - Newser
Technical analysis overview for Xilio Therapeutics Inc. stockQuarterly Trade Summary & Verified Momentum Stock Ideas - Newser
Can momentum traders help lift Xilio Therapeutics Inc.July 2025 Weekly Recap & Fast Exit/Entry Strategy Plans - Newser
Finanzdaten der Xilio Therapeutics Inc-Aktie (XLO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Xilio Therapeutics Inc-Aktie (XLO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Shannon James Samuel | Director |
Jun 17 '25 |
Buy |
0.69 |
25,000 |
17,215 |
70,000 |
| Russo Rene | PRESIDENT AND CEO |
Jun 16 '25 |
Buy |
0.68 |
36,289 |
24,680 |
281,172 |
| Frankenfield Christopher James | Chief Financial Officer |
Jan 02 '25 |
Sale |
0.98 |
6,954 |
6,841 |
12,421 |
| Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING |
Jan 02 '25 |
Sale |
0.98 |
1,803 |
1,774 |
3,197 |
| GILEAD SCIENCES, INC. | 10% Owner |
Dec 18 '24 |
Buy |
1.04 |
1,759,978 |
1,830,377 |
9,105,451 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):